New rules from the SEC and FCC, and the former’s own SIM swap incident, are likely to raise scrutiny on crypto firms to clamp down on a scourge of identity-hacks, says Andrew Adams, partner at Steptoe.
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
The drug, from Eli Lilly, was previously approved for treating diabetes. Read More Czytaj więcej We współpracy z:…
